YAPALI, S. Et Al. 2022. Real life efficacy and tolerability of Tenofovir Alafenamide Fumarate in patients with hepatitis-B virus-related cirrhosis. THE INTERNATIONAL LIVER CONGRESS , (Londrina, Brazil), 864.

YAPALI, S., GÖKCAN, H., DURAK, S., MELEKOĞLU ELLİK, Z., GÜZELBULUT, F., VATANSEVER, S., ... ARI, D.(2022). Real life efficacy and tolerability of Tenofovir Alafenamide Fumarate in patients with hepatitis-B virus-related cirrhosis . THE INTERNATIONAL LIVER CONGRESS (pp.864). Londrina, Brazil

YAPALI, SUNA Et Al. "Real life efficacy and tolerability of Tenofovir Alafenamide Fumarate in patients with hepatitis-B virus-related cirrhosis," THE INTERNATIONAL LIVER CONGRESS, Londrina, Brazil, 2022

YAPALI, SUNA Et Al. "Real life efficacy and tolerability of Tenofovir Alafenamide Fumarate in patients with hepatitis-B virus-related cirrhosis." THE INTERNATIONAL LIVER CONGRESS , Londrina, Brazil, pp.864, 2022

YAPALI, S. Et Al. (2022) . "Real life efficacy and tolerability of Tenofovir Alafenamide Fumarate in patients with hepatitis-B virus-related cirrhosis." THE INTERNATIONAL LIVER CONGRESS , Londrina, Brazil, p.864.

@conferencepaper{conferencepaper, author={SUNA YAPALI Et Al. }, title={Real life efficacy and tolerability of Tenofovir Alafenamide Fumarate in patients with hepatitis-B virus-related cirrhosis}, congress name={THE INTERNATIONAL LIVER CONGRESS}, city={Londrina}, country={Brazil}, year={2022}, pages={864} }